Environmental risk assessment of three selective serotonin reuptake inhibitors in the aquatic environment: A case study including a cocktail scenario

Environmental Toxicology and Chemistry

Volumn 30, Issue 1, 2011, Pages 254-261

  Styrishave, Bjarne ^a   Halling Sørensen, Bent ^a   Ingerslev, Flemming ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b The Danish Environmental Protection Agency EPA   (Denmark)

Author keywords

Antidepressants; Citalopram; Cocktail effect; Fluoxetine; Sertraline

Indexed keywords

ANTIDEPRESSANTS; CITALOPRAM; COCKTAIL EFFECT; FLUOXETINE; SERTRALINE;

BIODEGRADATION; BIOLOGICAL WATER TREATMENT; CONCENTRATION (PROCESS); DRUG PRODUCTS; HOSPITALS; PHOTODEGRADATION; PHOTOLYSIS; RISK ASSESSMENT; RISK PERCEPTION; SEWAGE; SEWAGE TREATMENT; SORPTION; TOXICITY; WASTEWATER; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

EFFLUENTS;

CITALOPRAM; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AQUATIC ENVIRONMENT; BIODEGRADATION; ENVIRONMENTAL RISK; HYDROLYSIS; INHIBITOR; ORGANIC COMPOUND; PHOTOLYSIS; SORPTION; WASTE TREATMENT; WASTEWATER;

ABIOTIC STRESS; ABSORPTION; AQUATIC ENVIRONMENT; ARTICLE; BIODEGRADATION; BIOTIC STRESS; CASE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL IMPACT ASSESSMENT; FLUID INTAKE; HUMAN; MENTAL HOSPITAL; PHOTOLYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SEWAGE EFFLUENT; SEWAGE TREATMENT; WASTE COMPONENT REMOVAL; WASTE WATER; WASTE WATER TREATMENT PLANT; WATER RETENTION;

BIODEGRADATION, ENVIRONMENTAL; CITALOPRAM; ENVIRONMENTAL MONITORING; FLUOXETINE; FRESH WATER; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEWAGE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

EID: 78650505134     PISSN: 07307268     EISSN: 15528618     Source Type: Journal    
DOI: 10.1002/etc.372     Document Type: Article

References (38)

1. Devane CL. 1997. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 19: 443-466.
2. Schultz MM, Furlong ET, Kolpin DW, Werner SL, Schoenfuss HL, Barber LB, Blazer V, Norris DO, Vajda AM. 2010. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: Occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ Sci Technol 44: 1918-1925.
3. Hiemke C, Härttner S. 2000. Pharmakokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85: 11-28.
4. Foran CM, Weston J, Slattery M, Brooks BW, Huggett DB. 2004. Reproductive assessment of Japanase medaka (Oryzias latipes) following a four-week flouxetine (SSRI) exposure. Arch Environ Contam Toxicol 46: 511-517.
5. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000 A national reconnaissance. Environ Sci Technol 36: 1202-1211.
6. Metcalfe CD, Miao XS, Koening BG, Struger J. 2003. Distribution of acidic and neutral drugs in the surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem 22: 2881-2889.
7. Vanderford BJ, Snyder SA. 2006. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ Sci Technol 40: 7312-7320.
8. Lajeunesse A, Gagnon C, Sauvé S. 2008. Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid-chromatography-tandem mass spectrometry. Anal Chem 80: 5325-5333.
9. Schultz MM, Furlong ET. 2008. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal Chem 80: 1756-1762.
10. Metcalfe CD, Chu S, Judt C, Li H, Oakes KD, Servos MR, Andrews DM. 2010. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ Toxicol Chem 29: 79-89.
11. Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD, Lewis RJ. 2005. Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24: 464-469.
12. Iwamatsu T, Toya Y, Sakai N, Yasutaka T, Nagata R, Nagahama Y. 1993. Effect of 5-hydroxytryptamine on steroidogenesis and oocyte maturation in pre-ovulatory follicles of the medaka Oryzias latipes Dev Growth Differ 35: 625-630.
13. Cerda J, Subhoder N, Reich G, Wallace RA, Selman K. 1998. Oocyte sensitivity to serotonergic regulation during the follicular cycle of the teleost Fundulus heteroclitus Biol Reprod 59: 53-61.
14. Fong PP. 2001. Antidepressants in aquatic organisms: A wide range of effects. In Daughton CG, Jones-Lepp TL, eds, Pharmaceutical and Personal Care Products in the Environment: Scientific and Regulatory Issues. American Chemical Society, Washington, DC, pp 264-281.
15. Kragh-Sørensen P, Fredricson-Overø K, Petersen OL, Jensen K, Parnas W. 1981. The kinetics of citalopram: single and multiple dose studies in man. Acta Pharmacol Toxicol 48: 53-60.
16. Ronfeld RA, Tremaine LM, Wilner KD. 1997. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet 32: 22-30.
17. Organisation for Economic Co-operation and Development. 1981. Hydrolysis as a function of pH. Guideline 111. OECD guideline for testing of chemicals, Paris, France.
18. Battersby NS. 1990. A review of biodegradation kinetics in the aquatic environment. Chemosphere 21: 1243-1284.
19. Schwarzenbach RP, Gschwend PM, Imboden DM. 1993. Environmental Organic Chemistry, 2nd ed. Wiley-InterScience, Hoboken, NJ, USA.
20. Environmental Protection Agency, Denmark. 1996. Activated Sludge Biodegradability Simulation Test. Environmental Project 337. Ministry of Environment and Energy, Copenhagen, Denmark.
21. European Union Commision. 1993. Technical Guidance on Risk Assessment. Part II: European Chemical Bureau. Institute of Health and, Consumer Protection, Ispra, Italy.
22. Tay JH, Chen XG, Jeyaseelan S, Graham NA. 2001. Comparative study of anaerobically digested and undigested sewage sludges in preparation of activated carbons. Chemosphere 44: 53-57.
23. Parvaresh A, Shahmansouri MR, Alidadi H. 2004. Determination of carbon/nitrogen ratio and heavy metal in bulking agents used for sewage composting. Iran J Public Health 33: 20-23.
24. Minagh E, Hernan R, ÓRourke K, Lyng FM, Davoren M. 2009. Aquatic ecotoxicology of the selective serotonin reuptake inhibitor sertraline hydrochloride in a battery of freshwater test species. Ecotoxicol Environ Saf 72: 434-440.
25. Henry TB, Kwon JW, Armbrust KL, Black MC. 2004. Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia Environ Toxicol Chem 23: 2229-2233.
26. Johnson DJ, Sanderson H, Brain RA, Wilson CJ, Solomon KR. 2007. Toxicity and hazard of selective serotonin re-uptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae. Ecotoxicol Environ Saf 67: 128-139.
27. Vasskog T, Berger U, Samuelsen PJ, Kallenborn R, Jensen E. 2006. Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway. J Chromatogr A 1115: 187-195.
28. Himmelsbach M, Buchberger W, Klampfi CW. 2006. Determination of antidepressants in surface and wastewater samples by capillary electrophoresis with electrospray ionization mass spectrometric detection after preconcentration using off-line solid-phase extraction. Electrophoresis 27: 1220-1226.
29. Kwon J-W, Armbrust KL. 2008. Aqueous solubility, n-octanol-water partition coefficient, and sorption of five selective serotonin reuptake inhibitors to sediments and soils. Bull Environ Contam Toxicol 81: 128-135.
30. Kwon J-W, Armbrust KL. 2005. Degradation of citalopram by simulated sunlight. Environ Toxicol Chem 24: 1618-1623.
31. Kwon J-W, Armbrust KL. 2006. Laboratory persistence and fate of fluoxetine in aquatic environments. Environ Toxicol Chem 25: 2561-2568.
32. Calamari D, Zuccato E, Castiglioni S, Bagnati R, Fanelli R. 2003. Strategic survey of therapeutic drugs in the Rivers Po and Lambro in Northern Italy. Environ Sci Technol 37: 1241-1248.
33. Diaz-Cruz MS, De Alda MJL, Barcelo D. 2003. Environmental behavior and analysis of veterinary and human drugs in soil, sediments and sludge. Trends Anal Chem 22: 340-351.
34. Vanderford BJ, Pearson RA, Cody RB, Rexing DJ, Snyder SA. 2003. Determination of an unknown system contaminant using LC/MS/MS. In Ferrer I, Thurman EM, eds, Liquid Chromatography/Mass Spectrometry, MS/MS and Time-of-Flight MS. Symposium Series 850. American Chemical Society, Washington, DC, pp 96-108.
35. Conners DE, Rogers ED, Armbrust KL, Kwon J-K, Black MC. 2009. Growth and development of tadpoles (Xenopus laevis) exposed to selective serotonin reuptake inhibitors, fluoxetine and sertraline, throughout metamorphosis. Environ Toxicol Chem 28: 2671-2676.
36. Fuller RW, Hemrick-Luecke SK, Littlefield ES, Audia JE. 1995. Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo. Prog Neuropsychopharmacol Biol Psychiatry 19: 135-149.
37. Paterson G, Metcalfe CD. 2008. Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere 74: 125-130.
38. Brooks BW, foran CM, Richards SM, Weston J, Turner PK, Stanley JK, Solomon KR, Slattery M, La Pont TW. 2003. Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142: 169-183.